​

Jasper Therapeutics (JSPR) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Jasper Therapeutics Revenue Highlights

00

Jasper Therapeutics Revenue by Period

Jasper Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Jasper Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Jasper Therapeutics Revenue by Quarter

DateRevenueChange
2025-03-31--100.00%
2024-12-31$1.17M100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$2.05M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Jasper Therapeutics generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Jasper Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
EQEquillium$41.09M$4.39M
XLOXilio Therapeutics$6.34M$1.72M
LYRALyra Therapeutics$1.53M$209.00K
INBXInhibrx Biosciences$200.00K$100.00K
IKNAIkena Oncology--
DSGNDesign Therapeutics--
EWTXEdgewise Therapeutics--
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
HOOKHOOKIPA Pharma--
JSPRJasper Therapeutics--
EPIXESSA Pharma--
ELDNEledon Pharmaceuticals-$192.00K
ORICORIC Pharmaceuticals--

JSPR Revenue FAQ

What is Jasper Therapeutics’s yearly revenue?

Jasper Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. JSPR's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Jasper Therapeutics’s quarterly revenue?

Jasper Therapeutics's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $1.17M, a 100.00% increase from the previous quarter (Q3 2024), and a -42.79% decrease year-over-year (Q4 2023). JSPR's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023).

What is Jasper Therapeutics’s revenue growth rate?

Jasper Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.